Nagve: Molbio Diagnostics announced its investment of $30 million in OptraSCAN. The strategic partnership enables OptraSCAN to accelerate the development and accessibility of digital pathology solutions powered by artificial intelligence
WomenNovember 1, 2025
Blogs & ArticlesNovember 1, 2025
Blogs & ArticlesNovember 1, 2025
WomenNovember 1, 2025
Blogs & ArticlesNovember 1, 2025
Blogs & ArticlesNovember 1, 2025
HealthNovember 15, 2024
Nagve: Molbio Diagnostics announced its investment of $30 million in OptraSCAN. The strategic partnership enables OptraSCAN to accelerate the development and accessibility of digital pathology solutions powered by artificial intelligence







